CN108117550B - 吡啶并[2,3-d]嘧啶类化合物的制备方法 - Google Patents
吡啶并[2,3-d]嘧啶类化合物的制备方法 Download PDFInfo
- Publication number
- CN108117550B CN108117550B CN201611073881.5A CN201611073881A CN108117550B CN 108117550 B CN108117550 B CN 108117550B CN 201611073881 A CN201611073881 A CN 201611073881A CN 108117550 B CN108117550 B CN 108117550B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- catalyst
- preparation
- molar ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611073881.5A CN108117550B (zh) | 2016-11-29 | 2016-11-29 | 吡啶并[2,3-d]嘧啶类化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611073881.5A CN108117550B (zh) | 2016-11-29 | 2016-11-29 | 吡啶并[2,3-d]嘧啶类化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108117550A CN108117550A (zh) | 2018-06-05 |
CN108117550B true CN108117550B (zh) | 2020-08-14 |
Family
ID=62226782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611073881.5A Active CN108117550B (zh) | 2016-11-29 | 2016-11-29 | 吡啶并[2,3-d]嘧啶类化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108117550B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101511829A (zh) * | 2006-09-08 | 2009-08-19 | 辉瑞产品公司 | 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮的合成 |
CN105008357A (zh) * | 2013-02-21 | 2015-10-28 | 辉瑞大药厂 | 选择性cdk4/6抑制剂的固态形式 |
-
2016
- 2016-11-29 CN CN201611073881.5A patent/CN108117550B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101511829A (zh) * | 2006-09-08 | 2009-08-19 | 辉瑞产品公司 | 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮的合成 |
CN105008357A (zh) * | 2013-02-21 | 2015-10-28 | 辉瑞大药厂 | 选择性cdk4/6抑制剂的固态形式 |
Also Published As
Publication number | Publication date |
---|---|
CN108117550A (zh) | 2018-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022161469A1 (zh) | 一种硫代乙内酰脲药物用中间体及其制备方法与用途 | |
WO2010069280A2 (en) | A method for the preparation of tizanidine hydrochloride | |
CN102617622A (zh) | 一种制备莫西沙星或其可药用盐及其中间体的方法 | |
CN110183445A (zh) | 莫西沙星及其衍生物的合成方法 | |
CN108117550B (zh) | 吡啶并[2,3-d]嘧啶类化合物的制备方法 | |
CN111349045A (zh) | 乐伐替尼的合成方法及新的中间体 | |
JP6714062B2 (ja) | アゾキシストロビンの調製方法 | |
CN111018782B (zh) | 9-氨基吖啶及其衍生物的制备方法 | |
CN109928933B (zh) | 2-氯-5-醛基嘧啶及其制备方法 | |
CN1680330A (zh) | 一种(r)-(-)-阿朴***的制备方法 | |
CN109761914B (zh) | 一种制备5-三氟甲基尿嘧啶的方法 | |
CN113292506B (zh) | 一种2-氨基-4,6-二氯-5-硝基嘧啶的制备方法 | |
CN107868055B (zh) | 一种马西替坦的制备方法 | |
CN105566429B (zh) | 一种奥贝胆酸1型的制备方法 | |
CN108117524B (zh) | 5-溴尿嘧啶的制备方法 | |
CN108658931A (zh) | 一种雷替曲塞关键中间体的制备方法 | |
CN108341770A (zh) | 一种索拉非尼化合物的制备方法 | |
CN115477653B (zh) | 一种曲拉西利关键中间体及曲拉西利的制备方法 | |
CN114524803B (zh) | 一种喹啉化合物中间体的合成方法 | |
CN113956267B (zh) | 一种抗肿瘤药物依喜替康甲磺酸盐的制备方法 | |
CN113121532B (zh) | 一种染料中间体的制备方法 | |
CN103012087A (zh) | 一种α,α'-双亚苄基环烷酮化合物的绿色合成方法 | |
CN109485639B (zh) | 一种舒尼替尼制备方法 | |
CN109851557B (zh) | 一种西他沙星有关物质d-3的制备方法 | |
CN108484497B (zh) | 一种3-氨基-7-氯喹啉的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Qingtong Inventor after: Chen Xudong Inventor after: Shan Xiaoyan Inventor after: Chen Yu Inventor before: Ma Qingtong Inventor before: Shan Xiaoyan Inventor before: Chen Xudong Inventor before: Chen Yu |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200040 No. 1320 West Beijing Road, Shanghai, Jingan District Patentee after: Shanghai Pharmaceutical Industry Research Institute Co.,Ltd. Patentee after: China Pharmaceutical Industry Research Institute Co.,Ltd. Address before: 200040 No. 1320 West Beijing Road, Shanghai, Jingan District Patentee before: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Patentee before: CHINA STATE INSTITUTE OF PHARMACEUTICAL INDUSTRY |